WHY ATTEND

13-16 October 2025
RAI Congress Centre, Amsterdam

Premium Conference

Learn from world KOLs in vaccines on the latest in technology platforms, global health, pandemic preparedness, therapeutic vaccines, zoonotic diseases and development of the whole life cycle. Attend one event for all of your vaccine knowledge needs.

➤

Busy Exhibition

With a footfall of 3000+ attendees, exhibitors will get to speak directly to their target market, expand sales leads, strengthen and establish their brand and close deals with customers on-site.

➤

Limitless Networking

Get access to our dedicated event app (live 3 weeks before the event), see all of our 3000+ attendees and set up 1-2-1 meetings to maximise your ROI in attending the congress.

➤

Start-up Zone

Meet start-ups at the leading vaccine congress. Meet new companies that can help your business or investors that can take you to the next level.

➤

Workshops

Host or participate in our pre-congress workshops where we deep dive into topics including new technologies, biothreats, alternative vaccine delivery routes, and global equity with all stakeholders.

➤

Working Groups

Be part of a NEW format – our working groups. Replacing roundtables, these sessions are intimate discussions and one of the best ways to find out what your target audience wants.

➤

Poster Zone

Meet up and coming academics and spin out organisations at the poster zone where you will be presented with unpublished research that is changing the field of vaccine development. Applications open soon.

➤

Media Zone

The media zone will be bustling with all of the who’s who in the vaccine world. Witness live interviews and use our zone to announce press releases and social media outreach to maximise your presence.

➤

Amsterdam

We’re moving to Amsterdam! The heart of where the EMA and RIVM are, you will have some of the strongest biotech and academic networks right by our doorstep. Join us at our newest venue for a state of the art experience.

➤

Super Early Bird Tickets Available - Save €2,300

Join 2,500 attendees at the Europe's largest vaccine event.

This is your best opportunity in 2025 to network with like-minded professionals.

Past Speakers | 280 Subject Matter Experts

Jeffrey Almond
Former VP Discovery R&D, Sanofi & Visiting Professor
University of Oxford - Oxford Vaccine Group

Francesco Berlanda Scorza
Director GVGH
GSK Vaccines for Global Health (GVGH)
Cedric Bogaert
Chief Executive Officer
myNEO Therapeutics

Andrew Catchpole
CSO
hVIVO
Mark Emalfarb
Chief Executive Officer
Dyadic International Inc

Marion Gruber
Vice President of Public Health and Regulatory Affairs
IAVI
Bassam Hallis
Deputy Director, Vaccine Development & Evaluation Centre
UK Health Security Agency

Mateusz Hasso-Agopsowicz
Technical Officer
World Health Organization
Hans Keirstead
Chief Executive Officer
AIVITA Biomedical, Inc.

Jerome Kim
Director General
IVI
Geert Leroux Roels
Professor Emeritus
Gent University

Ab Osterhaus
Director of Research Center For Emerging Infections and Zoonoses and Professor
University of Veterinary Medicine Hannover
Jan Poolman
Head Bacterial Vaccine Discovery and Early Development
Executive Advisor

Ruben Rizzi
SVP Global Regulatory Affairs
BioNTech SE
Nigel Temperton
Professor and Director
University of Kent

Joris Vandeputte
Past President
IABS
Maria Elena Bottazzi
Co-Director of Texas Children's Hospital Center for Vaccine Development
Baylor College of Medicine

Dennis Christensen
Head of Global R&D
Croda Pharma
Edward Kelley
Chief Global Health Officer
ApiJect

Ofer Levy
Director, Precision Vaccines Program
Boston Children's Hospital
Haiko Pillu
Director Operations CPU
SGS

Helge Dorfmuller
Principal Investigator
University of Dundee
Walter Straus
Vice President, Clinical Safety & Risk Management
Moderna Therapeutics

Antonio Garcia Maldonado
Investment Professional, Strategic Investment Fund
Bill and Melinda Gates Foundation
Francesco Pappalardo
Deputy Director, Department of Drug and Health Sciences
University of Catania

Michael Caldwell
Assoc VP Vaccine Research
Meharry Medical College
Katie Ewer
Senior Project Leader, Malaria vaccines
GSK

Lenny Moise
VP, Research
SeromYx
Hanna Nohynek
Chief Physician
National Institute for Health and Welfare

Ajoy Chakrabarti
Portfolio And Platform Lead
The Bill & Melinda Gates Foundation
Aaron Esser-Kahn
Professor
University of Chicago

Mark Howarth
Sheild Chair of Pharmacology
University Of Cambridge
Robert Paris
VP, Infectious Diseases Development
Moderna

Jeremy Salt
Chief Executive Officer
The Vaccine Group
Daniel Wolfe
Deputy Direct, BARDA CBRN Medical Countermeasures
Biomedical Advanced Research And Development Authority

Chad Costley
Chief Executive Officer
BlueWillow Biologics, Inc.
Ingrid de Visser-Kamerling
Associate Research Director
Stichting Centre for Human Drug Research

Anne Moore
NIBRT PI
University Colleague Cork
Roland Zahn
Senior Scientific Director - Head Preclinical Immunology - Viral Vaccines
Johnson & Johnson

Andrea Guerra
Regional Clinical Director, Vaccines, Europe
MSD
James Cummings
Chief Medical Officer
Vaxart

Petro Terblanche
Chief Executive Officer
Afrigen Biologics (Pty) Ltd
Sean Tucker
CSO
Vaxart

Christopher Bussineau
Principal Consultant
Biologics Consulting Group, Inc.
Juliana Cassataro
Professor
University of San Martin

Marco Cavaleri
Head of Public Health Threats
European Medicines Agency
Trang Gisler
Senior Director, Government and Public Health Services
PPD, part of Thermo Fisher Scientific

Jenny Hendriks
Head Biomarkers and Clinical Immunology
Janssen Vaccines & Prevention B.V.
Tim Peterson
Scientific Director, Dermal Drug Delivery
Kindeva Drug Delivery

Mukul Pore
Executive Director
Intox Pvt Ltd
Marco Pravetoni
Center Director & Rick L. Seaver Endowed Professor of Psychiatry
University of Washington School of Medicine

Melanie Saville
Chief Scientific Officer
PATH
Joe Smyser
Chief Executive Officer
PGP (The Public Good Projects)

Satoshi Uchida
Professor
Tokyo Medical and Dental University (TMDU)
Sebastian Ulbert
Deputy Director
Fraunhofer-Institute for Cell Therapy and Immunology

Thomas Waite
Deputy Chief Medical Officer
UK Department of Health
Nico Vandaele
Prof. dr.
KU Leuven, Access-To-Medicines Research Centre

Maya Cabot
Senior Product Manager
Integral Molecular
Margherita Coccia
Director
GSK

Wian de Jongh
Chief Executive Officer
adaptvac
Kyle Doolan
Director of Research
Integral Molecular

Michael Kowarik
CSO
LimmaTech Biologics AG
Marie-Louise Lunn
Senior Product Manager
Novo Nordisk Pharmatech

Isabel Oliver
Director General of Science & Research and Chief Scientific Officer
UK Health Security Agency
Karina Pasquevich
researcher
UNSAM

Mojca Tajnik Sbaizero
Head of Product-Application Area, Process Development Dept. for Viral Vectors and Vaccines
Sartorius BIA Separations
Sultan Abduljawad
Global Scientific Affairs Advisor
BioNTech

Gemma Lahuerta
Parenteral Development Director
LABORATORIO REIG JOFRE, S.A.
Simona Rondini
Head Bacterial Projects and Senior Project Leader
GSK Vaccines

Taylor Sexton
Executive Director
Medical Countermeasures Coaltion
Miriam Sturkenboom
Professor in RWE & Head, Department of DataScience and Biostatistics, University Medical Center Utrecht & President
VAC4EU

Nicolas Burdin
Global Head of R&D
Clover Pharma
Tim Cooke
CEO
Omniose

Carla Vinals
VP Head of Regulatory Strategy
Moderna
Ulf Niklas Blomberg
Executive Director
Innovative Health Initiative

Gabrielle Breugelmans
Director of Epidemiology and Data Science
CEPI
Luigi Buonaguro
Lab Director
Istituto Nazionale Tumori "Pascale"

Valerie Chambard
Supply Chain Lead
CEPI
Christine Dahlke
Translational Immunology Lead
CEPI

Jaime Espin
Professor
Andalusian School Of Public Health
Nicola Esposito
QC Molecular Biology Assays Manager
Advaxia Biologics

Ricarda Finnern
CSO
LenioBio GmbH
Ana Maria Henao-Restrepo
Co-Lead R&D Blueprint for epidemics, Health Emergencies Programme (WHE),
World Health Organisation

Emilie Karafillakis
European Director, Vaccine Confidence Project
London School of Hygiene and Tropical Medicine
Teresa Lambe
Calleva Head of Vaccine Immunology & Professor of Vaccinology & Immunology
University of Oxford

Andreea Iordache
Manager, Science & Regulatory Affairs
Vaccines Europe
Irene Nkumama
Malaria Programme Manager
European Vaccine Initiative (EVI)

Sibilia Quilici
Executive Director
Vaccines Europe
Birgitte Rønø
Chief Scientific Officer
Evaxion Biotech A/S

Avencia Sánchez-Mejías García
Chief Executive Officer
Integra Therapeutics
Amy Shurtleff
Head of Animal Models
CEPI

Andrea Tattersall
Director Laboratory Operations
Revvity
Thomas Trolle
Director, Bioinformatics & AI/ML
Evaxion Biotech

Charlotte Vernhes
Director Scientific and Medical Affairs
Vaccines Europe
Jay Evans
Chief Scientific and Strategy Officer
Inimmune

Holy Akwar
Deputy Head of Department, AMR & Vet Products
World Organization for Animal Health (WOAH)
Montse Daban
Director of Strategic Foresight and International Relations
BIOCAT

David Farcas
Director, Chile
Yelcho
Cari Kessing
Director, Laboratory Operations
IQVIA Laboratories

Swati Gupta
VP, Head of Emerging Infectious Diseases and Epidemiology
International AIDS Vaccine Initiative
Kelli Aufderheide
Director of Lab Decentralized Trial Solutions
IQVIA Laboratories

George Simeon
CEO
Curevo Vaccine
William Ampofo
Executive Director
African Vaccine Manufacturing Initiative

Joffrey Benford
SES, Director of CMA, and Deputy Head of Contracting Activity ASPR, HHS
HHS, ASPR, BARDA, CMA
Lucy Chappell
Chief Scientific Adviser
UK Department of Health and Social Care

Jack Evans
Vice President, Site Operations
EmVenio Research
Catherine Hoath
Global Regulatory Strategy Lead
CEPI

Enrique Mañán
Chief of Staff, Contracts Division
US DHHS, BARDA
Florence Meunier
Therapeutic Area Head, Global Regulatory Affairs
Sanofi

Martin Pech
Senior Manager Development & Head of Production CTM
IDT Biologika
Martin Rabel
Global Sales Specialist | Biopharma Services
Cytiva

Volker Sandig
Chief Scientific Officer
ProBioGen AG
Aleksandra Sikora
Professor
Oregon State University College of Pharmacy

Jane True
VP, mRNA CSI & Global Pandemic Security Lead
Pfizer
Wolfgang Philipp
Principal Adviser, Chief Science Officer
European Commission Health Emergency Preparedness & Response (HERA)

Mario Barro
President / CEO
GIVAX Inc.
Kaidre Bendjama
CSO
NEC OncoImmunity AS

Robert Choy
Director of Research and Development
PATH
Jonathan Luke Heeney
CSO
DIOSynVax Ltd

Nektaria Karavas
Business Development Director
Aptar Pharma
Dave Liebowitz
Senior Vice President, Early-Stage Clinical Development
Inovio

Kilian Mullet
Senior Director , Commercial supply strategy, Pfizer Global Supply
pfizer
Thierry Rolling
Director, Clinical Development Infectious Diseases
BioNTech SE

Tyler Sandberg
Product Manager, ELISpot & FluoroSpot
MABTECH
Lucas Silva
Senior Specialist
Aptar Pharma

Miriam Taegtmeyer
Professor of Global Health
London School of Hygiene and Tropical Medicine
Andrew Ustianowski
Interim National Executive Director, Research Delivery Network
NIHR

Cesar Vinces
Sr. Director Regulatory Innovation & International Policy
Accumulus Synergy
Nicola Yallup
Head of Lifesciences, Partnership & Growth
NIHR

Xinhao Ye
Director of CMC Management
WuXi Vaccines
Monika Ballmann
Associate Director, Viral Vector and Vaccine Development Department
Batavia Biosciences

Sumi Biswas
Associate Professor, Jenner Institute, University of Oxford & President and CSO
Spybiotech Limited
David Burkhart
COO
Inimmune Corp

Stefaan De Koker
VP technology and innovation
etherna
Dean Geribo
Vice President, Corporate Security
Moderna

Jae Myun Lee
Scientific Advisor
Yonsei University
Donald Loveday
Head Of Business Development
SPI Pharma Inc

Zeil Rosenberg
Executive Vice President, Medical
Tonix Pharmaceuticals
Vic Suarez
Principal Growth Partner
Blu Zone Bioscience

Lance Turtle
Chair and Honorary Consultant Physician in Infectious Diseases; Deputy Head, Department of Clinical Infection, Microbiology and
University of Liverpool
Arno van der Ark
Project manager
Intravacc

Heather Zar
Professor Department of Paediatrics and Child Health & Director, School of Child and Adolescent Health
University of cape town
Chase Kempinski
Chief Executive Officer
EVAX Inc.

Maria Koufali
Programme Director
UK Vaccine Innovation Pathway
Asaf Poran
Senior Director, Systems immunology
BioNTech

Suzanne Welten
Scientific Manager Immunology
Johnson & Johnson
Marta Antunes
Director, EU EMEA CMC Regulatory Affairs
MSD

Javier Cid
Senior Research Scientist, Real-World Evidence
Evidera, part of the PPD clinical research business of Thermo Fisher Scientific
Wayland Coker
Chief Supply Chain Strategist
Dept of Health & Human Services/ASPR

Bernard Fritzell
Independent Consultant
TuBerculosis Vaccine Initiative
Dagmar Garcia Rivera
R&D vicedirector
Finlay Vaccine Institute

Jose Jimeno
CEO
Vaxtrials
Arlene Joyner
Director, Office of Industrial Base Management and Supply Chain (IBMSC),
HHS/.ASPR/IBMSC

Alessandro Manenti
Chief Development Officer
Vismederi
Shelley Mclendon
Senior Vice President, Vaccine and Infectious Disease
ICON Clinical Research LLC’

Narcisa Mesaros
VP, Medical Science & Strategy
PPD clinical research business of Thermo Fisher Scientific
Sarah Rosen
Senior Director, Non-Interventional Studies
Evidera part of the PPD clinical research business of Thermo Fisher Scientific

Claire Sears
Head of Business Transformation
EMS Healthcare
Uta Tschiesner
Senior Director, Global Medical Affairs
BioNTech

Elissa Weitzman
Associate Professor, Director of Research
Boston Children's Hospital, and Harvard Medical School
Edward Wright
President Government and Public Health Solutions
ICON PLC

Hamilton Bennett
Sr. Director Vaccine Access and Partnerships
Moderna
Christian Brander
PI
Irsicaixa Research Institute

Denis Cavert
Chief Executive Officer
Vaxxel
Sudha Chivukula
Head Discovery Biology
Sanofi

Marlene Espinoza
Director and Product Development Team Leader
International AIDS Vaccine Initiative (IAVI)
Rosaria Esposito
Global Field Scientist VaxArray®
bioMérieux

Eric Fevre
Research Fellow and Zoonoses Group Leader, ILRI & Chair of Veterinary Infectious Diseases
University of Liverpool & International Livestock Research Institute
Alec Freyn
Principal Scientist
Moderna

Holger Heyn
Co-Founder & CSO
Omniscope
Robert Huebner
Principal Consultant
Latham BioPharm Group

Karin Jooss
EVP & Head of R&D
Gritsone bio
Randy Lacey
Field Application Scientist
InDevR

Stephen Lockhart
Director, Senior Consultant
HURST GRANGE ASSOCIATES
Gerben Marsman
Head of Alliance Management
Vaccine Formulation Institute

Romain Micol
Chief Executive Officer
Combined Therapeutics
Marta Murreddu
Business Development Manager
Cerba Research

Elizabeth Norton
Associate Professor
Tulane University
Giovanna Riggall
Head of Heath Supply Chain
Unimed

Meta Roestenberg
Clinical Head, Controlled Human Infection Center
Leiden University Medical Center (Netherlands)
Kristyna Sala
Applications Scientist for Imaging & BioPharma
Molecular Devices

Nitin Shetty
Chief Technical Officer
Bioneeds India Private Limited
Marc van Pruijssen
General Manager Clinical Trial Services & Logistic Excellence, Senior Vice-President Global Logistics and CTOS
Cerba Research

PJ Kim
Vice President, Business Development
ApiJect